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Muscle regeneration in the adult occurs in response to damage at expenses of a
population of adult stem cells, the satellite cells. Upon injury, either physical or genetic,
signals released within the satellite cell niche lead to the commitment, expansion
and differentiation of the pool of muscle progenitors to repair damaged muscle. To
achieve this goal satellite cells undergo a dramatic transcriptional reprogramming to
coordinately activate and repress specific subset of genes. Although the epigenetics
of muscle regeneration has been extensively discussed, less emphasis has been put
on how extra-cellular cues are translated into the specific chromatin reorganization
necessary for progression through the myogenic program. In this review we will focus
on how satellite cells sense the regenerative microenvironment in physiological and
pathological circumstances, paying particular attention to the mechanism through
which the external stimuli are transduced to the nucleus to modulate chromatin
structure and gene expression. We will discuss the pathways involved and how
alterations in this chromatin signaling may contribute to satellite cells dysfunction
during aging and disease.
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Muscle Regeneration
Adult muscle is a very stable tissue, with very few fibers being replaced during the normal
life of the organism. However, it has a remarkable capacity to regenerate in response to tissue
damage. Upon injury, either physical or genetic, changes in the injured microenvironment (i.e.,
necrosis of damaged fibers, recruitment of the inflammatory infiltrate and release of cytokines
and growth factors) lead to the activation, expansion and differentiation of a population of
muscle-resident stem cells called satellite cells (Chargé and Rudnicki, 2004). Satellite cells
were originally named after their anatomical position beneath the basal lamina of muscle
fibers and are characterized by the expression of the transcription factor Pax7 (Mauro, 1961;
Cornelison and Wold, 1997; Seale et al., 2000; Chargé and Rudnicki, 2004). Upon activation,
satellite cells start to proliferate and up-regulate the early Muscle Regulatory Factors (MRFs)
Myf5 and MyoD. After several rounds of cell divisions cells down-regulate Pax7 and induce
the expression of the late MRFs (Myogenin and MRF4) and of the cell cycle inhibitor p21.
The differentiation program then culminates with the expression of structural and contractile
proteins and the fusion of differentiating muscle cells to repair the damaged fibers. Not all
activated satellite cells complete the differentiation program and after asymmetric division
a small subset of Pax7-positive/MyoD-negative progenitors exit the cell cycle and re- enter
quiescence to replenish the satellite cell pool (Chargé and Rudnicki, 2004; Wang et al., 2014).
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To achieve their goal satellite cells need to undergo a
complex remodeling of chromatin that temporally activates and
represses discrete transcriptional programs. Such remodeling
is determined by changes in the composition of the satellite
cell niche that are transmitted to the nucleus through several
cytoplasmic cascades. Here we will discuss how such cascades
signal to the chromatin of satellite cells to define the
transcriptional response that allows them to proceed through the
myogenic program.
At the molecular level, the signaling pathways and
transcription factors orchestrating muscle regeneration have
been extensively studied. Briefly, myogenesis is controlled
by the sequential action of lineage determination markers
(i.e., Pax3/Pax7) and early and late MRFs, that act together with
Mef2 and Six proteins to recruit chromatin modifying complexes
and regulate muscle gene expression. Reprogramming of
satellite cells nucleus entails the coordinated activation and
repression of discrete subset of genes to progress through
the myogenic program. For instance, committed myoblats
keep myogenic identity but repress late muscle genes while
continuing to proliferate. Finally, cells switch-off lineage-
determination genes and genes necessary for cell cycle
progression and activate late muscle-differentiation markers
(reviewed in Palacios and Puri, 2006; Guasconi and Puri,
2009; Segalés et al., 2014). Recently, the introduction of
high throughput genome-wide studies has been fundamental
to provide a deeper insight into the transcriptional and
epigenetic programs that modulates myogenesis. By combining
ChIP-seq to gene expression analysis, the group of Tapscott
showed that MyoD binds to thousands of non-canonical
sites both in myoblasts and myotubes, which coincides with
local histone hyperacetylation but not necessarily with gene
activation. Upon induction of differentiation MyoD-binding
to a preferred E-box motif (CAGGTG) located within an
accessible chromatin context leads to muscle-specific gene
expression (Cao et al., 2010; Fong et al., 2012). Therefore,
both genetic (the specific E-box sequence) and epigenetic
(local chromatin structure) determinants are fundamental
for the activation of the correct differentiation program.
Recently, Asp et al. provided an exhaustive analysis of
the differentiation-associated epigenetic changes in muscle
cells (Asp et al., 2011) and identified novel muscle-specific
enhancers associated to MyoD binding (Blum et al., 2012;
Blum and Dynlacht, 2013). To add complexity to this
scenario, the lab of Sartorelli showed that some muscle-
specific enhancers are actually transcribed in what have
been called enhancer RNAs (eRNAs), which function as
novel epigenetic regulators of gene expression (Mousavi
et al., 2013). It is therefore becoming increasingly clear that
modulating the epigenome is an essential mechanism that
allows muscle cells to proceed through the differentiation
program.
Before getting in depth into the mechanisms by which
signaling molecules act to modulate the epigenome of satellite
cells, it is important to highlight some of the key aspect of
epigenetics and its role in regulating gene expression during
cellular differentiation.
Epigenetics: From the DNA Sequence to
Differential Gene Expression
Historically introduced by Conrad Waddington in 1942, the
term epigenetics was coined to explain why specialized cells
in a multi-cellular organism exert different functions despite
having the same genetic material. This is accomplished by the
addition of epigenetic modifications, covalent modifications of
the DNA and associated proteins that determine the activation
and repression of discrete transcriptional programs during
development, cellular differentiation and disease (reviewed in
Bernstein et al., 2007; Bergman and Cedar, 2013).
The first layer of epigenetic regulation is the covalent
modification of DNA. Mammalian genomes are globally
methylated (Eckhardt et al., 2006; Bergman and Cedar, 2013). In
eukaryotes, themajority of DNAmethylation occurs on cytosines
that precede a guanine nucleotide (CpGs). CpG dinucleotides
are not evenly distributed through the genome. Ninety eight
percent of the dinucleotides are located in regions of low-
CpG density, are usually methylated through the genome and
may be demethylated in a tissue-specific fashion (Bergman
and Cedar, 2013). The remaining two percent of CpGs cluster
in regions termed CpG islands (Bird et al., 1985; Gardiner-
Garden and Frommer, 1987), stretches of 500--1000 base
pairs of DNA that have a higher CpG density than the rest
of the genome and are usually kept free of methylation in
all tissues (Bergman and Cedar, 2013). Unmethylated CpG
islands are associated to DNA sequences more accessible
to transcription factor binding, resulting in enhancement of
gene expression (Tazi and Bird, 1990; Ramirez-Carrozzi et al.,
2009; Choi, 2010). On the contrary, when CpG islands are
methylated gene expression under their control is silenced. This
is achieved through the binding ofMethyl-CpG-binding proteins
(MBD; Nan et al., 1993; Hendrich and Bird, 1998; Hendrich
et al., 2001), which recognize 5-methyl cytosine (5mC) and
recruit repressor complexes leading to changes in chromatin
structure (Nan et al., 1998; Ng et al., 1999; Wade, 2005).
Aberrations in the DNA methylation pattern are a common
feature of many cancers and have been also observed in
aging tissues (Feinberg and Tycko, 2004; Bergman and Cedar,
2013).
DNA methylation is catalyzed by DNA methyltransferases
(Dnmts). Of them, Dnmt1 is responsible for maintaining
methylation after DNA replication whereas Dnmt3a and
Dnmt3b catalyze de novo DNA methylation (Goll and Bestor,
2005). It has been recently demonstrated that DNA methylation
is reversible thanks to the action of the family of ten-eleven
translocation methylcytosine dioxygenases (Tet). Tet proteins
modify 5mC to generate 5-hydroxymethyl-cytosine (5hmC;
Kohli and Zhang, 2013; Piccolo and Fisher, 2014). 5hmC can be
then subjected to subsequent chemical modifications producing
different intermediates that are recognized and cleaved off
by TDG (thymine DNA glycosylase) and replaced with an
unmethylated cytosine (He et al., 2011). The conversion of 5mC
to 5hmC impairs the binding of the repressive methyl-binding
protein such as MeCP2 and plays an important role in regulating
gene expression (Valinluck et al., 2004).
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The DNA methylation pattern influences and is also
influenced by histone modifications, the second layer of
epigenetic modifications. In eukaryotic cells the DNA is packed
together with histones and other proteins to fit into the limited
space of the nucleus, in a structure called chromatin. The
basic unit of the chromatin is the nucleosome that is made
up of 147 base pairs of DNA wrapped around an octamer
of histone proteins called ‘‘core’’, which contains two copies
of each histone, (H2A, H2B, H3, H4) (Luger et al., 1997).
Each histone has an N-terminal tail that protrudes from the
nucleosome core and is target of different types of covalent
modifications such as acetylation, methylation, o-glycosilation
and ubiquitylation. Post-translational modifications of histones
tails (and bodies) regulate chromatin structure and accessibility
(Bannister and Kouzarides, 2011; Tessarz and Kouzarides, 2014).
Acetylation of several lysine residues is usually associated with
gene activation and is catalyzed by histone acetyltransferases
(HATs) such as p300 and PCAF, while it is erased by
histone deacetylases (HDACs; Kouzarides, 1999). Differently
from histone acetylation, methylation occurs on both lysines and
arginines and can either activate and repress gene expression (Ng
et al., 2009). Amongst the histone methyltransferases (HMTs),
particular interest has been put on the enzymes responsible for
H3K27 and H3K9 di- and tri-methylation as these modifications
are considered key regulators of gene repression. The first lysine
methyltransferase identified was Suv39h1 (KMT1A) that targets
H3K9. H3K9 me2/3 mark is recognized by HP1 proteins, which
recruit Suv39h1 to the chromatin to spread the repressive mark
(Lachner et al., 2001; Bannister and Kouzarides, 2011). Ezh2, the
catalytic subunit of the Polycomb Repressive Complex 2 (PRC2),
tri-methylates K27 on H3 to keep genes in a repressed state
(Margueron and Reinberg, 2011; Riising et al., 2014). H3K27me3
creates a docking site for PRC1, which ubiquitylates H2A, leading
to Dnmt recruitment and to amore compact chromatin structure
(Sparmann and van Lohuizen, 2006). However, this view has
been challenged recently and two studies have shown PRC1-
mediated H2AK119ub is sufficient to trigger PRC2 recruitment
(Blackledge et al., 2014; Cooper et al., 2014). Histone methylation
is reversible and histone demethylases for most of the modified
residues have been described (Klose and Zhang, 2007; Ng et al.,
2009).
Based on the different combinations of modifications,
chromatin can either activate (i.e., H3K4me3, H3K9Ac) or
repress (H3K9me2/3, H3K27me3) gene expression. Further, in
some cases it can prime associated genes for future regulation
(Schneider et al., 2004; Azuara et al., 2006; Bannister and
Kouzarides, 2011; Margueron and Reinberg, 2011). For example,
in undifferentiated embryonic stem (ES) cells, developmental
regulatory genes contain bivalent domains that are characterized
by the co-existence of opposing modification in terms of
activation (H3K4me3) and repression (H3K27me3). This allows
keeping ‘‘marked’’ genes poised in a silenced state for being
rapidly activated or repressed upon differentiation process
(Azuara et al., 2006; Voigt et al., 2013).
DNA and histone modifications are therefore essential
components of an epigenetic program that ultimately modulates
chromatin accessibility to transcription factors and chromatin
remodelers and needs to be tightly regulated. For instance, it
has been previously shown that hyperacetylated chromatin is
preferentially remodeled by chromatin remodeling complexes,
whereas hypoacetylation leads to a more compact structure.
Chromatin remodeling is accomplished by different families
of proteins that use the energy derived from ATP to disrupt
or modify nucleosome positioning (Saha et al., 2006). The
best-studied chromatin remodelers are the SWI/SNF and ISWI
complexes (Deuring et al., 2000; Martens and Winston, 2002).
Both families contain a conserved ATPase subunit and a set of
additional, conserved core members. SWI/SNF ATPases Brg1
and Brm contain one or multiple bromo-domains that bind
acetylated histone tails (Winston and Allis, 1999; Kasten et al.,
2004) while ISWI has two domains (SANT and SLIDE) that allow
the recognition of the histone tails and the DNA linker (Grüne
et al., 2003). In addition, SWI/SNF and ISWI complexes contain
structural subunits that contribute to differential gene-specific
targeting.
In summary, the high dynamicity and plasticity of the
chromatin, which can go from permissive to refractory structures
and vice-versa, is an important pre-requisite for the proper
control of gene transcription. Here we will discuss how
chromatin function is modulated during muscle regeneration in
response to external cues to activate and repress discrete subset
of genes.
When Signaling Cascades get into the
Nucleus
Satellite cells receive a myriad of signals from the regenerative
microenvironment that guide the cells through the multi-step
process leading to activation of a quiescent stem cells pool,
expansion of the activated muscle progenitors and induction
of the terminal differentiation program to induce regeneration
of damaged muscles. Necrotic cues released from the damaged
fibers, cytokines secreted by the inflammatory infiltrate, growth
factors, free radicals, soluble proteins and changes in the extra-
cellular matrix composition alter the satellite cell niche and need
to be interpreted (Guasconi and Puri, 2009).
The precise composition of the extra-cellular environment
is therefore fundamental to determine the gene expression
profile that will guide the step-wise progression from quiescent
satellite cells into multinucleated myofibers. Such information
is transmitted to the cell nucleus through several cytoplasmic
cascades that ultimately target components of the myogenic
transcriptosome and chromatin modifying enzymes to regulate
gene expression. Here we will review our current knowledge
on how extra-cellular signals are transmitted to the chromatin
of muscle cells to coordinately regulate the gene expression
program needed for muscle regeneration. We will discuss
the pathways and key signaling molecules involved as well
as the downstream effectors and the changes in chromatin
structure and function necessary to activate or repress discrete
gene expression programs. The exquisite coordination of
such programs may be subject to alterations by both cell-
extrinsic changes (changes in the microenvironment) and cell-
autonomous modifications (i.e., changes in the metabolome or
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in the epigenome). Understanding how this chromatin signaling
modulates cell fate will assist us in the rational design of
pharmacological therapies to improve satellite cell function in
physiological (i.e., aging) or pathological (i.e., muscular diseases)
conditions.
Calcium-Dependent Chromatin Signaling
The importance of chromatin signaling in the control of muscle
gene expression was first highlighted by work from Olson’s
laboratory. In their pioneer work McKinsey et al. showed how
calcium calmodulin kinase (CamK) activity is necessary to release
class II HDACs from Mef2 transcription factors at the onset of
muscle differentiation (McKinsey et al., 2000). Mef2 belong to
the MCM1-Agamous-Deficiens-Serum response factor (MADS)
box domain family of transcriptional regulators that cooperate
with the MRFs (Myf5, MyoD, Myogenin and Mrf4) to activate
muscle gene transcription (Puri and Sartorelli, 2000; Potthoff
and Olson, 2007). In proliferating myoblasts Mef2 binds to and
recruits class II HDACs (HDAC4 and 5) to the chromatin of
muscle genes, acting as a transcriptional repressor (Lu et al.,
2000). Upon induction of differentiation, activation of CamK in
response, at least in part, to Insulin Growth Factor I (IGF-1),
leads to phosphorylation of HDAC5 on two serine residues, S259
and S498. Phosphorylation of these residues induces the binding
of the chaperon protein 14-3-3 with consequent activation of the
nuclear export signal and export to the cytoplasm (McKinsey
et al., 2001). Further, Ca2+ -sensitive HDAC4, which, in spite
of its name lacks of known endogenous deacetylase activity, has
been shown to regulate satellite cell function through promoting
activation of Pax7-positive cells, although the leadingmechanism
remains largely unknown (Choi et al., 2014b).
High intracellular Ca2+ concentration also increases
the activity of calcineurin serine/threonine phosphatase,
which in turns dephosphorylates NFAT (Nuclear Factor of
Activated T cells) transcription factors (Friday et al., 2000).
Dephosphorylation unmasks a nuclear localization signal and
induces NFATs nuclear translocation and gene activation
(Hogan et al., 2003). Several NFAT isoforms are present in
muscle cells (Hoey et al., 1995; Parsons et al., 2003; Calabria
et al., 2009) and knock out studies have suggested different
temporal expression patterns and function of the different
isoforms (Horsley et al., 2001; Kegley et al., 2001; Horsley
and Pavlath, 2002). Further, in vitro studies have dissected the
contribution of calcineurin/NFATs in satellite cells and activated
myoblasts, showing that NFATs regulate the myogenic program
at least at two different steps: first, NFATc isoforms regulates
Myf5 expression in reserve cells (Friday and Pavlath, 2001),
then NFATc3 cooperates with MyoD to regulate Myogenin
gene expression in early differentiating myoblasts (Armand
et al., 2008). Finally, calcineurin is also involved in fiber-type
specification at the later steps of differentiation in an NFATc3
independent process (Delling et al., 2000).
Growth Factor Activated Signaling Pathways
While CamK activity is necessary to release class II HDACs from
Mef2, binding of class I HDAC to MyoD in proliferating,
undifferentiated myoblasts is controlled by cell cycle
dependent changes in the phosphorylation status of pRb.
Dephosphorylation of Rb upon differentiation sequesters class
I HDACs and allows MyoD-dependent transcription (Mal et al.,
2001; Puri et al., 2001). Further, we previously showed that
another family of protein kinases, namely Akt1/2, is required
to recruit HATs such as p300 and CBP to the chromatin of
muscle genes (Serra et al., 2007). Akt1, which is activated by
IGF-1 in muscle cells, phosphorylates the C-terminal of p300 on
two serines, S1734 and S1834. Phosphorylated p300 is recruited
to the chromatin to ultimately lead to the hyperacetylation of
histones H3 and H4 at target genes. Moreover, Akt1/2 signaling
is involved in the disengagement of chromatin repressors
such as Polycomb proteins upon differentiation of muscle
cells (Serra et al., 2007). This is consistent with the finding
that Akt1 directly phosphorylates Ezh2, the catalytic subunit
of PRC2 on S21 in cancer cells, an event that modulates
binding to histone H3 (Cha et al., 2005). p300 and PCAF are
important not only for histone acetylation but also for the
post-translational modification of tissue specific factors such as
MyoD and Mef2 (Sartorelli et al., 1999; Dilworth et al., 2004;
Ma et al., 2005; Serra et al., 2007). Acetylation of MyoD on
residues K99, K102 and K104 is essential for recruitment to a
discrete subset of genes at defined stages of the muscle program
(Di Padova et al., 2007) and for proper myogenesis both in
vitro and in vivo (Sartorelli et al., 1999; Duquet et al., 2006;
Di Padova et al., 2007). Acetylation of Mef2, in turn, increases
DNA binding and transcriptional activity (Ma et al., 2005).
MyoD and Mef2 transcription factors can be also modulated
by lysine methylation. In particular, it was shown that G9a
methyltransferase not only increases H3K9me2 at MyoD-target
genes to repress muscle gene expression (Ling et al., 2012b;
Wang et al., 2013), but also directly interacts with MyoD and
Mef2 to methylate them in K104 and K267 respectively, reducing
their transcriptional activity (Ling et al., 2012a; Choi et al.,
2014a).
In addition to IGF-1 several other growth factors have
been show to signal to the chromatin in regenerating muscles.
Amongst them, Hepatocyte Growth Factor (HGF) and members
of the Transforming Growth Factor β (TGFβ) superfamily are
fundamental in the regulation of satellite cells function.
TGFβs are potent repressors of myogenesis (Burks and Cohn,
2011). Of them, Myostatin (GDF8) is a well-known negative
regulator of muscle differentiation that signals through binding
to Activin type II receptors. Binding to type II receptors
induces heterodimerization with type I receptors (Alk4/5)
(Rebbapragada et al., 2003). Activated receptor phosphorylates
Smad2/3, inducing binding to Smad4 and nuclear translocation
(Moustakas, 2002). In muscle cells it has been shown that
phosphorylated Smad3 binds to and interferes with MyoD and
Mef2 transcriptional activity (Langley et al., 2002; Liu et al.,
2004). On the contrary, Smad7, an antagonist of the canonical
TGFβ/Smad signaling, promotes myogenesis through MyoD
binding and activation (Zhu et al., 2004; Kollias et al., 2006).
Myostatin function can be blocked by the action of Follistatin,
which can be induced in muscle cells by treatment with HDAC
inhibitors (HDACis; Iezzi et al., 2004). Follistatin is involved
in myoblast fusion in vitro and contributes to the beneficial
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effect of HDACi treatment in vivo in a mouse model of muscle
regeneration (Iezzi et al., 2004; Minetti et al., 2006). Further,
it was recently shown that the EGF-CFC family of proteins
(Shen and Schier, 2000) also antagonizes Myostatin function
during muscle regeneration. In particular, Cripto, the founder
member of the family, is re-expressed in activated satellite cells
and positively regulates myogenesis, interfering with Myostatin-
mediated Smad2 phosphorylation (Guardiola et al., 2012).
HGF is a heparin binding protein located in the extra-cellular
matrix of muscle fibers. Upon injury or mechanical stretch, HGF
is released from its anchor in muscle fibers by serum proteases
and binds to the surface receptor c-Met, present in satellite
cells (Tatsumi et al., 1998, 2002; Miyazawa, 2010). HGF has
been shown to regulate satellite cell proliferation and function
(Tatsumi et al., 1998; Yamada et al., 2010). Further it was recently
shown that high concentrations of HGF are necessary for the
re-entry of satellite cells into quiescence through a mechanism
involving Myostatin up-regulation (Yamada et al., 2010). Both
HGF and the inflammatory cytoquine IL-6 induce the activity of
the oxidative stress sensor Nrf2 in myoblasts. Nrf2 is involved
in satellite cell proliferation and repression of the myogenic
program through direct down-regulation of Myogenin gene
(Al-Sawaf et al., 2014). On the other hand, signaling through
HGF/c-Met activates the mammalian target of rapamycin
(mTOR) pathway in satellite cells via the PI3K/Akt cascade.
mTOR is a main sensor of the metabolic status of the cell,
modulating the cell response to variations in nutrient availability.
Although extensive work has been done on the upstream
regulators of the pathway, the downstream effectors are less
known (for a detailed review on mTOR signaling, see Laplante
and Sabatini, 2012). The best-characterized responses are the
regulation of protein synthesis through phosphoryation of
translational regulators such as eIF4E binding protein or S6
kinase and the regulation of lipid metabolism (Laplante and
Sabatini, 2012). Although little endogenous mTOR is found
in the nucleus, the pathway has been associated with the
modulation of gene expression in skeletal muscle through the
transcription factors PGC1α and YY1 (Cunningham et al.,
2007; Blattler et al., 2012). A recent study showed mTOR
activation upon limb-muscle injury switches quiescent satellite
cells in the contro-lateral limb into what it has been called a
quiescent ‘‘alert’’ state or Galert. Such state allows satellite cells
to quicker activate in response to injury. Consistent with a role
of the mTOR pathway in regulating the metabolic status of
the cell, amongst the transcriptional changes associated to the
‘‘alert’’ response there is an enrichment in transcripts associated
to metabolism and mitochondrial activity. The alert state is
reversible and the morphological and transcriptional changes
turn to those of normal quiescent satellite cells when mTOR
signaling ceases. It will be interesting to dissect the molecular
pathways and epigenetic changes associated to this reversible
quiescence (Rodgers et al., 2014).
Inflammatory Signals
The inflammatory infiltrate recruited to the site of lesion is
the main source of secreted cytokines such as interleukina-1,
interleukina-6 or Tumor Necrosis Factor (TNF) that activate
muscle resident cells (Stoick-Cooper et al., 2007). In satellite
cells, several signaling cascades respond to cellular stressors by
converting inflammatory cues into the epigenetic information
that controls gene expression (Lluís et al., 2006; Lassar, 2009).
In some circumstances a single signal transducer may control
multiple steps of gene regulation. One of the best studied
examples of multi-layered control of gene expression by a
signaling cascade is provided by the family of Mitogen Activated
Protein Kinases (MAPK) α, β, γ and δ (Cuenda and Cohen,
1999; Zetser et al., 1999; Wu et al., 2000). p38 is activated
in response to either inflammatory cytokines such a TNF or
amphoterin/HMGB1, cell-to-cell contact and growth factors
such as TGFβ in satellite cells (reviewed in Guasconi and Puri,
2009). Previous studies have shown how p38 kinases α and
β contribute to the assembly of the myogenic transcriptosome
on the chromatin of muscle loci, leading to the consequent
activation of gene expression. p38α and β promote Mef2
transcriptional activation (Zetser et al., 1999), MyoD-E47
heterodimerization (Lluís et al., 2005) and recruitment of
SWI/SNF chromatin remodeling complex (Simone et al.,
2004; Serra et al., 2007; Forcales et al., 2012) and Ash2L-
containing mixed-lineage leukemia (MLL) methyltransferase
complex (Rampalli et al., 2007) to the chromatin of muscle genes.
By contrast, activation of p38γ in satellite cells represses MyoD
transcriptional activity by direct phosphorylation, which leads
to the association with the H3K9 methyltransferase Suv39h1
(KMT1A) (Gillespie et al., 2009). Further, we have recently
shown that p38α signaling to PRC2 represses the determination
gene Pax7 in satellite cells undergoing terminal differentiation,
an event that is necessary for cell cycle exit (Palacios et al., 2010;
Mozzetta et al., 2011). Activation of p38α/β downstream kinase
Msk1 has been shown to regulate a chromatin switch between
Ezh2-containing and Ezh1-containing PRC2 complexes at the
onset of differentiation via phosphorylation of S28 on histone
H3 (Stojic et al., 2011). Interestingly, Ezh1-containing complexes
have been associated to polII recruitment and transcriptional
activation in differentiating myoblasts, challenging the common
view of PRC2 complexes as chromatin repressors (Mousavi et al.,
2012).
Thus, p38 signaling can either activate or repress gene
expression in satellite cells, depending on the activation status
of specific p38 isoforms, or chromatin recruitment with
specific modifying complexes. Furthermore, evidence supports
the notion that chromatin-associated p38 kinases can control
gene transcription by directly targeting components of the
transcription machinery (Chow and Davis, 2006; Pokholok et al.,
2006; de Nadal and Posas, 2010), suggesting a general role of p38
signaling in the control of genome redistribution of chromatin-
modifying complexes in response to extrinsic signals.
Underlying a further layer of complexity, the same cytokine
may modulate different intra-cellular cascades that ultimately
converge to the chromatin of muscle precursors. For instance,
in addition to inducing p38α/β activation, TNF also regulates
NF-κB activation in muscle cells. Work from the Guttridge
lab showed that the TNF/NF-κB pathway repressed Notch
expression both in satellite cells and C2C12 myoblasts through a
mechanism involving Ezh2 and Dnmt3b (Acharyya et al., 2010).
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Amongst the signaling pathways activated in response
to inflammatory cues in muscle, the Jun Activated Kinase
(JAK)/STAT pathway responds to cytokines such as IL-6 or
leukemia initiating factor (LIF). The pathway is activated upon
binding of IL-6 to the IL-6R-gp130 receptor which leads to JAK
activation and phosphorylation of Stat proteins on tyrosines
residues. Phosphorylated Stats are able to heterodimerize and
translocate into the nucleus (Stark and Darnell, 2012; Muñoz-
Cánoves et al., 2013). In muscle satellite cells, nuclear Stat3
binds the regulatory regions of target genes, including MyoD,
to regulate their expression. Consistent with a role in regulating
myogenic progression (Sun et al., 2007; Wang et al., 2008),
genetic depletion or pharmacological inactivation of JAK2
and/or Stat3 expanded a population of Pax7-positive, MyoD-
negative cells and improved muscle regeneration (Price et al.,
2014; Tierney et al., 2014).
Developmental Programs Re-Activated in Adult
Stem Cells
Several signaling pathways essential for embryonic myogenesis
have been shown to be re-activated during regeneration in
the adult and to play a fundamental role in the activation,
commitment and differentiation of satellite cells. Here we will
discuss the contribution of Notch, Wnt, Sonic Hedgehog (Shh)
and Bone Morphogenetic Proteins (BMPs) pathways to adult
muscle regeneration.
The Notch signaling pathway plays a fundamental role in the
establishment of cell fate decisions in several tissues. In muscle
it has been shown to be essential both during embryogenesis
and in the adult. Activation of the Notch signaling starts with
the expression of Notch ligand delta-like (Dll) in differentiating
cells. Dll binds and activates the membrane receptor Notch in
satellite cells, leading to the cleavage of the cytoplamic portion
of the protein and nuclear translocation of the intracellular
domain (NICD; Schroeter et al., 1998). NICD is a potent
transcriptional activator that binds the regulatory regions of
target genes together with Rbpj, the main downstream effector
of the pathway (Kopan and Ilagan, 2009). It is currently widely
accepted that the Notch pathway, which is activated upon
injury in quiescent satellite cells, is required for maintaining
the homeostasis of the satellite cells compartment and is
involved in regulating proliferation and self-renewal, keeping
myoblast in an undifferentiated state (Conboy and Rando,
2002; Wen et al., 2012). By using conditional knock out mice
two different labs showed that Rbpj-depleted satellite cells
prematurely differentiate while they fail to undergo replication,
leading to premature exhaustion of the satellite cell compartment
(Bjornson et al., 2012; Mourikis et al., 2012a,b). Genome-
wide analysis demonstrated dynamic Rbpj chromatin binding
in response to Notch activation in muscle cells, together with
NICD and the acetyltransferase p300. A detailed analysis of
the chromatin signature at Rbpj-bound regions, showed that
different chromatin modifications are present at constitutive
vs. inducible genes and confirmed the major role of Rbpj as
a transcriptional activator (Castel et al., 2013). Notch signaling
is switched off through ubiquitin-mediated degradation of the
protein, which is directed by the cellular adaptor Numb. Numb
factors comprise a family of four cytoplasmic proteins that
mark Notch for proteome-mediated degradation through the E3
ubiquitin ligase Itch (McGill and McGlade, 2003). Numb has
been implied in the replenishing of the satellite cell compartment
by meditating asymmetric division of activated satellite cells
(Shinin et al., 2006). Further, Numb-depletion has been shown to
impair proliferation and differentiation of satellite cells through
up-regulation of the cell cycle inhibitor p21 and Myostatin
(George et al., 2013).
Work from Rando’s lab showed that a temporal switch
between Notch and Wnt signaling is necessary for adult
myogenesis (Brack et al., 2008). Wnt proteins comprise a
family of 19 glycoproteins that play a fundamental role
during embryonic myogenesis and adult homeostasis (for a
detailed review on the contribution of Wnt signaling to
myogenesis, see von Maltzahn et al., 2012). Secreted Wnts bind
to Frizzed (Fzd) receptors, located in the plasma membrane
of target cells (Sethi and Vidal-Puig, 2010). When bound
to the receptor, Wnt elicits a variety of cellular responses
through the activation of several intra-cellular cascades. The
best known of such cascades, the canonical Wnt pathway, starts
the activation of heterotrimeric G proteins and Dishevelled
(Dsh) and the recruitment of Axin to the Fzd co-receptor
Low Density Protein receptor (LPR)-related protein. This
recruitment inactivates the βcatenin degradation complex,
consisting of Axin, APC and glycogen synthase kinase 3 beta
(GSK-3β). Before Wnt stimulation βcatenin levels are regulated
through GSK-3β mediated phosphorylation, which targets the
protein to proteasome-mediated degradation. Upon binding
of Wnt ligands, stabilized βcatenin accumulates and is able
to translocate into the nucleus, where it binds members of
the TCF and LEF families of transcription factors. Nuclear
βcatenin acts as a transcriptional co-activator (Katoh, 2007;
Nusse, 2008). The canonical Wnt pathway may co-exist with
other βcatenin-independent signaling, such as the activation of
phospholipase C (PLC), CamkII or protein kinase C (PKC) (all
of which lead to an increase in the intracellular Ca2+ levels)
the phosphatidil-inositol 3 kinase (PI3K)/Akt/mTOR axis, the
Protein Kinase A (PKA)/CREB pathway (Chen et al., 2005)
and the planar-cell polarity (PCP) pathway (Kühl, 2004; Le
Grand et al., 2009; von Maltzahn et al., 2011). The latest
is involved in the remodeling of the cytoskeleton, acting
through Fzd, Vang1, Dsh and Prickle (Montcouquiol et al.,
2003; Vladar et al., 2009) Although it has not been formally
proved, it was suggested the PCP pathway could modulate
Carm1 (Prmt4)-dependent methylation of Pax7 in activated
satellite cells (Kawabe et al., 2012). Carm1 is an arginine
methyltransferase important for Pax7-mediated activation of
Myf5 in asymmetrically dividing cells through recruitment of
Mll1/2 methyltransferase (McKinnell et al., 2008; Kawabe et al.,
2012). It also regulates muscle-specific microRNAs, SWI/SNF-
mediated chromatin remodeling and Mef2 transcriptional
activity (Chen et al., 2002; Dacwag et al., 2009; Mallappa et al.,
2011).
The role of the Wnt proteins in adult muscle regeneration
is complex as illustrated by the amount of family members
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whose expression is modulated during regeneration (Polesskaya
et al., 2003; Brack et al., 2008). In regenerating muscle Wnts are
released by the myofibers (Polesskaya et al., 2003) whereas the
Fzd receptor is activated only in satellite cells (Brack et al., 2008).
Numerous studies have helped to clarify the multi-step control
of myogenesis through sequential activation of different Wnt
ligands and pathways. First, Wnt7-activation of the PCP pathway
stimulates symmetric expansion of satellite cells (Le Grand
et al., 2009). Then, activation of the canonical Wnt/βcatenin
pathway was proposed to be required for the differentiation
of progenitor cells (Polesskaya et al., 2003; Rochat et al., 2004;
van der Velden et al., 2006; Brack et al., 2008). Consistently,
genetic depletion of Bcl9, the mammalian homologue of the
Wnt co-regulator in drosophila legless, in Pax7-positive cells
abrogates nuclear localization of βcatenin and impairs injury-
mediated muscle regeneration (Brack et al., 2009). However, a
recent study has challenged this idea, showing that although the
Wnt pathway is activated during regeneration, this activation is
transient and it is the subsequent Wnt inactivation, rather than
activation, that is necessary for proper regeneration (Murphy
et al., 2014). Finally, it has been shown that, upon injury,
Wnt signaling is also able to induce Pax7 expression in a
subpopulation of muscle-resident CD45+ stem cells through a
canonical βcatenin pathway (Polesskaya et al., 2003). However,
the contribution of this population of CD45+ cells to normal
adult myogenesis is controversial and it is probably limited to
pathological conditions such as muscular dystrophies, acting
as a compensatory mechanism to the continuous waves of
degeneration ad regeneration that lead to the exhaustion of the
satellite cells compartment.
BMPs are members of the TGFβ super-family. As with
the canonical TGFβ pathway binding of BMPs to type I and
II receptors induces phosphorylation of Smad 1, 5 and 8.
Phosphorylated Smad1/5/8 interact with Smad4 to form an
heterodimer that translocates to the nucleus and binds the
chromatin of target genes (Canalis et al., 2003). Upon muscle
injury, type IA BMP receptor is activated in satellite cells, and
Smad proteins are phosphorylated. Activation of the pathway
induces satellite cells proliferation while blocking differentiation
(Ono et al., 2011). At the onset of differentiation, the increase
of BMP antagonists such as Noggins or Chordin antagonizes
BMP signaling to allow satellite cells differentiation (Friedrichs
et al., 2011; Ono et al., 2011). Further, it was previously shown
that Notch signaling is necessary for BMP-induced block of
differentiation, highlighting the functional interplay amongst the
two pathways (Dahlqvist et al., 2003).
Hedgehog (hh) is an evolutionary conserved pathway
essential for tissue morphogenesis during development. The
pathway is activated upon interaction of the extra-cellular ligands
Shh, Ihh and Dhh with the transmembrane receptor Patched1
(Ptch1), which leads to the activation of smoothened (Smo)
and translocation to the nucleus of Gli transcription factors
(Jiang and Hui, 2008). Of the developmental programs that are
reactivated upon muscle injury the role of Shh as a regulator
of stem cell function in adult muscle has been by far the less
studied. It was recently shown that the primary cilia activate
Shh at the initial stages of muscle differentiation and is essential
for proper differentiation (Fu et al., 2014). Shh activation
induces proliferation of ex vivo cultured mouse satellite cells
while inhibiting terminal differentiation. In addition, upon
induction of differentiation, Shh regulates caspase-3 activation
and apoptosis (Koleva et al., 2005). On the contrary, a different
study using primary cultures of chicken myoblasts points out to
a role of the signaling pathway both in myoblasts proliferation
and differentiation through the MAPK/ERK and Akt1 pathways
(Elia et al., 2007). Recently it was shown Shh is reactivated during
muscle injury in vivo and pharmacological inactivation of the
pathway reduces the number of myogenic progenitors at the
site of lesion and impairs regeneration (Straface et al., 2009).
Despite the fact little is known on how Shh modulates chromatin
structure in adult muscle cells, it was previously shown that Gli2,
together with Zic1 and Pax3, activates Myf5 epaxial enhancer
during somitogenesis (Himeda et al., 2013). Consistent with a
role in regulating master regulatory factors, works on developing
limbs have mapped genome-wide Gli3 binding by ChIP-seq,
showing Shh-responsive genes are associated to gene categories
such as development and morphogenesis and are enriched in
transcriptional regulators (Vokes et al., 2008; Shi et al., 2014).
Further, a recent study has shown that Shh induces an epigenetic
switch consisting on disengagement of PRC2 and recruitment of
the H3K27me3 demethylase Jmjd3 at target loci in responsive
fibroblasts, leading to gene activation (Shi et al., 2014). If similar
mechanisms are active also in satellite cells still needs to be
elucidated.
Redox Status
Upon injury, inflammatory cytokines can alter the physiological
redox status of skeletal muscle stem cells, a fundamental
prerequisite for muscle regeneration. Important players in redox
status determination are Nitric Oxide (NO), Reactive Oxygen
Species (ROS) and the NAD+/NADH ratio.
NO is a free radical synthesized from the amino acid
L-arginine by three different isoforms of NO synthase (NOS;
Nathan and Xie, 1994). In skeletal muscle NO is produced
constitutively by neuronal type NO isoform (nNOS; Nakane
et al., 1993; Silvagno et al., 1996) that controls its physiological
production to hinder a potential toxicity. NO has been described
as an epigenetic molecule (Colussi et al., 2008; Nott et al., 2008)
capable of inducing global epigenetic modification in Duchenne
muscular dystrophy (DMD; Colussi et al., 2009). In DMD, the
absence of dystrophin causes delocalization of the dystrophin-
associated complex (DAPC) from the cytoskeleton of muscle
fibers membrane, leading to structural destabilization of the
sarcolemma (Matsumura et al., 1994; Ervasti and Sonnemann,
2008). DAPC displacement determines the dissociation of its
interactor, the sarcolemma neuronal NO synthase (nNOS) from
the same site, causing an alteration in NO production (Brenman
et al., 1995). In healthy muscle, NO deposits S-nytrosilation
on HDAC2, which is released from the chromatin, an
event that activates a specific pattern of gene expression,
including the activation of several microRNAs. Conversely, in
dystrophic muscles a decrease of nNOS activity reduces HDAC2
S-nytrosilation, increasing chromatin binding and determining
the repression of target genes and microRNAs. Amongst these,
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miR-1 repression up-regulates G6PD levels, which sensitizes
muscle cells to physiological production of free radicals. This
contributes to high oxidative stress levels observed in DMD
(Cacchiarelli et al., 2010). When dystrophin is rescued by exon
skipping, the recovery of correct nNOS localization on the
membrane induces chromatin disengagement of HDCA2 and
re-expression of its target genes, contributing to late muscle
differentiation (Cazzella et al., 2012).
Differently from NOS, ROS production occurs at different
locations in muscle fiber including the sarcoplasmic reticulum,
transverse tubules, sarcolemma and the cytosol but the main
sites are the mithocondria (Barja, 1999). Changes in redox status
of muscle fibers modify kinases and phosphatases activities
causing alterations in gene expression (Chiarugi and Cirri,
2003; Torres and Forman, 2003). For example p38 MAPK
and JNK are activated not only in response to inflammatory
cytoquines but also in response to ROS production (Cuschieri
and Maier, 2005) Increases in ROS concentration induces a
strong depletion of the glutathione (GSH) pool that leads
to NF-κB activation and reduction of MyoD expression,
impairing myogenesis (Guttridge et al., 1999; Ardite et al.,
2004). NF-κB is known for its negative regulation of skeletal
muscle differentiation (Buck and Chojkier, 1996; Langen et al.,
2001) even though in response to ROS alteration is also
able to promote the activity of inducible NOS whose role in
muscle differentiation is controversial (Kaliman et al., 1999;
Piao et al., 2005). Another protein, p66Shc, an isoform of Src
homology 2 domain containing transforming protein 1 (Shc),
is phosphorylated in response to elevated ROS levels, negatively
contributing to myogenesis. p66Shc KO mice show higher
regenerative capacity and differentiation of skeletal muscle stem
cells compared to wt mice. Probably, active p66Shc produces
superoxide anions, which deplete available NO by forming
peroxynitrite, which is not generated in KO mice (Zaccagnini
et al., 2007). Moreover at high ROS concentration, the ratio of
NAD+/NADH is shifted in favor of NAD+, which promotes the
activity of a family of NAD+-dependent HDACs, the sirtuins.
Sirt1 (the mammalian homologue of yeast Sirtuin2 (Sir2))---
mediates MyoD deacetylation and inhibition of transcription
(Fulco et al., 2003). Sirt1 senses variations in NAD+/NADH
ratio during skeletal muscle cell differentiation (MacDonald and
Marshall, 2000). In undifferentiated cells, where this ratio is
high, MyoD is kept inactive by Sirt1 mediated hypoacetylation
whereas when such ratio decreases, skeletal muscle cells start
to differentiate. Recently Abdel-Khalek et al. ascribed to Sirt3,
a mitochondrial NAD+ dependent deacetylase, a role in the
regulation of myoblast differentiation (Abdel Khalek et al., 2014).
Differently from Sirt1 that is highly expressed in proliferating
myoblasts, Sirt3 expression starts to increase when C2C12 cells
arrive at confluence and its levels are kept elevated during
differentiation. Interestingly, Sirt3-depleted cells show a block
of differentiation, high levels of ROS, a decrease in manganese
superoxide dismutase (MnSOD) activity and an inhibition of
Sirt1 expression (Abdel Khalek et al., 2014). It would be
interesting to clarify the mechanism by which Sirt3 regulates
Myogenin and MyoD expression and why Sirt1 is not up-
regulated upon Sirt3 depletion.
All together, these data demonstrate that the maintenance
of cellular redox homeostasis, as a result of a crosstalk among
different free radicals, represents another layer for regulating
muscle differentiation through chromatin signaling.
Mechano-Transduction
Due to their particular anatomical position, muscle stem cells
are strongly exposed to physical and mechanical cues such as
contraction and/or changes in the extra-cellular matrix stiffness
(Dupont et al., 2011; Gilbert et al., 2011). Cells convert these
mechano-stimuli into biochemical and nuclear signals through
the Yap and Taz mediators (Dupont et al., 2011) that usually
control cell growth and differentiation. Yap and Taz are the
nuclear transducers of the Hippo pathway (Pan, 2010).
The Hippo pathway is a signal transduction pathway involved
in development, cell function, regeneration and organ size in
many tissues and is altered in several human diseases including
muscular dystrophy and cancer (Tremblay and Camargo, 2012;
Yu and Guan, 2013; Tremblay et al., 2014; Wackerhage et al.,
2014). The central Hippo cascade comprises upstream elements
such as the STE20-like protein kinases 1 and 2 (Mst1 and Mst2)
and the large tumor suppressor kinases 1 and 2 (Lats1 and
Lats2). Phosphorylation and subsequent activation of Lats1/2 by
Mst1/2 induces Yap/Taz phosphorylation (Huang et al., 2005)
Phosphorylation of the best-characterized phospho-sites on Yap
(S127) and on its analogous Taz (S89) determines their retention
and inactivation in the cytosol by 14-3-3 proteins (Basu et al.,
2003; Wackerhage et al., 2014). In response to different stimuli
such as G-protein coupled Receptor (GPCR) signaling (Yu et al.,
2012), mechano-stimuli (Dupont et al., 2011) and apico-basal
polarity (Huang et al., 2005) Yap and Taz are dephosporylated
and translocate to the nucleus where they are recruited to
the chromatin through binding to several transcription factors
(Hong and Guan, 2012).
In muscle cells Taz and Yap associate with TEAD
transcription factors (TEA domain), which bind to MCAT
elements (muscle C, A and T; 5′-CATTCC-3′) located in
the promoter or enhancer regions of key genes that regulate
commitment (MyoD, Myf5, Mrf4), proliferation (Cyclin D1)
and differentiation (Myogenin) of satellite cells. Both Yap and
Taz are expressed in skeletal muscle (Jeong et al., 2010; Watt
et al., 2010). The group of Wackerhage was the first to assess the
expression of Yap in skeletal muscle cells. In particular they have
shown that in myoblasts, unphoshorylated Yap is localized in the
nucleus where positively controls the expression of proliferation
genes. Conversely, as C2C12 undergo differentiation, Yap (S127)
phosphorylation increases and the protein translocates from the
nucleus to the cytosol where it is kept inactive (Watt et al., 2010).
Moreover Yap stimulates proliferation of activated satellite cells
and prevents their differentiation by controlling expression
of genes associated with cell cycle, ribosome biogenesis and
modulation of myogenic differentiation (Judson et al., 2012).
In contrast to what observed for Yap, ectopic expression of
Taz promotes myogenic differentiation through a cooperative
interaction with MyoD that increases its binding to DNA
(Jeong et al., 2010). Taz has been shown to interact also with
Pax3 during development (Murakami et al., 2006). Jeong et al.
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demonstrated Taz levels increase after muscle injury in mice
suggesting it is also involved in muscle regeneration (Jeong et al.,
2010). Under differentiation conditions, translocation of Taz to
the nucleus is required for enhancing the expression of genes
such asMyogenin, Mhc and Mck. This process can be stimulated
by selenoproteinW which induces Taz nuclear translocation by
interrupting its binding with 14-3-3 protein and consequently
increasing myogenic differentiation (Jeon et al., 2014). Recently,
compounds that promote myogenesis through Taz activation in
C2C12 cells have been characterized and shown to induce an
increase in Taz expression, interaction with MyoD and MyoD
recruitment to the chromatin during the initial phase of the
muscle differentiation program (Park et al., 2014). Collectively
these data point out to Yap and Taz as novel components of
the muscle transcriptosome and suggest they could be potential
therapeutic targets in muscular dystrophies. Their opposite
effects on proliferation and differentiation suggest that fine-
tuned modulation of Taz and Yap activity might be a good
strategy for increasing muscle regeneration and amelioration of
diseased phenotypes.
Altogether, the data discussed here suggest that signaling to
the chromatin in response to the regenerative microenvironment
plays a crucial role during muscle regeneration. They are
summarized in Figure 1.
Age-Dependent Decline of Satellite Cell
Function
Aging is associated to a loss of the homeostatic and regenerative
potential in all tissues and organs. In muscle, it is reflected on a
loss of muscle mass and strength (sarcopenia) and to an impaired
regeneration potential associated to a dysfunction of the satellite
cell compartment (Brack and Rando, 2007).
Both cell-intrinsic changes and changes within the
regenerative microenvironment are associated with the stem cell
loss of function that occur with age. For instance, replicative
damage, proteomic changes (i.e., accumulation of damaged
macromolecules) and changes in the epigenome and the
proteome have been shown to affect stem cell function in old
tissues (Liu and Rando, 2011; García-Prat et al., 2013; Sinha et al.,
2014). Amongst the cell-intrinsic changes, modification of the
epigenetic profile, including changes in the DNA methylation
patterns and post-translational histone modifications are
particularly interesting, as they are potentially reversible. Recent
work has shown a progressive increase in DNA methylation
in aging muscle (Day et al., 2013; Jin et al., 2014; Ong and
Holbrook, 2014; Zykovich et al., 2014). Interestingly, key studies
in tumor and aged cells indicate that de novo DNA methylation
in the adult is usually restrained to a subset of CpG islands,
most of which are PRC2 target regions (Schlesinger et al., 2007;
Bergman and Cedar, 2013). Consistent with this, satellite cells
isolated from old mice show altered levels and distribution of
H3K27me3 (Liu et al., 2013). The functional interplay between
PRC2 and the DNAmethylation machinery in aged satellite cells
likely contributes to the impaired regeneration potential of old
muscles and could represent novel pharmacological target to
improve muscle function in aged individuals.
On the other hand, elegant parabiotic studies showed that
changes in the regenerative environment of old muscles regulate
satellite cell function (Conboy et al., 2005; Brack et al., 2007;
Sinha et al., 2014). For instance, attenuated Notch signaling leads
to reduced satellite cells proliferation and impaired regeneration
in aged muscle. Muscle regeneration can be recovered by
ectopic activation of Notch or by exposing old animals to a
young environment (Conboy et al., 2005). On the contrary, a
progressive increase in Wnt signaling with age alters muscle
stem cell fate (Brack et al., 2007; Doi et al., 2014), inducing a
myo-to-fibrogenic conversion of muscle progenitors that leads
to increased fibrosis in vivo (Brack et al., 2007). As in the case
of impaired Notch signaling, the fibro-adipogenic conversion
observed in old muscles is reversible and can be reduced
by exposing mice to conditioned serum from young animals.
Conversely, in vivo activation of the pathway in young mice by
injection of Wnt3A increases fibrotic deposition (Brack et al.,
2007). Finally, it was recently shown that the TGFβ member
Growth Differentiation Factor 11 (GDF11) also reverses the
age-related changes in satellite cells dysfunction (Sinha et al.,
2014).
The contribution of an old inflammatory infiltrate to
the impaired regenerative response of aged muscles can be
further predicted by the elevated levels of cytokines such as
IL-1, IL-6 and TNF observed in old muscles (Phillips and
Leeuwenburgh, 2005; Dirks and Leeuwenburgh, 2006). In a
recent study Trendelenburg et al. showed that elevated levels of
IL-1 and TNF block differentiation of human myoblasts through
activation of a signaling pathway involving TGFβ activated
kinase (TAK1)/p38/NF-κB and leading to increased expression
of ActivinA (Trendelenburg et al., 2012). Increased levels of TNF,
together with alterations in the pathway of FGFR1, also lead
to aberrant activation of the p38α/β cascade in satellite cells
derived from old muscles. Two recent studies have highlighted
the importance of p38α/β in maintaining satellite cells function
and homeostasis during their lifespan, showing that increased
p38α/β activity leads to a cell-autonomous defect in satellite cells
self-renewal and activates a senescence program. This p38α/β-
dependent decline in satellite cells function with age cannot
be overcome by exposure to a young microenvironment but
instead is partially reversed when satellite cells are treated with
the p38α/β inhibitor SB203580 (Bernet et al., 2014; Cosgrove
et al., 2014). Although in these experiments p38α/β blockade
was performed ex vivo prior to satellite cell transplantation,
pharmacological manipulation of the p38α/β signaling has
been achieved also in vivo through the use of antibodies
against TNF receptor (Palacios et al., 2010). Acute treatment
with neutralizing TNF antibodies expands a population of
Pax7+, differentiation-competent satellite cells in young animals
(Palacios et al., 2010), whereas long-term treatment with
the same antibodies have been shown to have a beneficial
effect on muscle regeneration (Radley et al., 2008; Huang
et al., 2009). If such beneficial effects are also obtained in
old mice needs to be investigated. Altogether these studies
highlight the potential impact of pharmacological approaches
in recovering satellite cell function in diseased and aged
muscles.
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FIGURE 1 | The genetic and epigenetic signaling governing muscle regeneration. Schematic representation of the signaling pathways and downstream
chromatin effectors that regulate the transition from activated satellite cells to multinucleated myotubes in response to regeneration cues.
In vivo pharmacological manipulation of a discrete
chromatin signaling has in fact been the strategy adopted
by the groups of Rudnicki and Sacco to stimulate the
function of old satellite cells. In this case, interfering with
an altered IL6/JAK/Stat3 signaling through the use of
JAK/STAT inhibitors increases the regeneration potential
of old and dystrophic muscles (Price et al., 2014; Tierney
et al., 2014), revealing its potential for pro-regenerative
therapy to counteract the impaired regeneration observed
with age.
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Even if it is becoming increasingly clear that satellite cells
malfunction is highly modulated by age-related changes in the
surrounding microenvironment, a gap of knowledge persists
on how alterations in the old regenerative environment and
cell-intrinsic changes (i.e., changes in the metabolism or in
the epigenetic profile) converge to modulate the function
of aged satellite cells. The relative contribution of aberrant
environmental cues and cell-intrinsic changes to aged satellite
cells function can now be partially explained by work in
Muñoz-Cánoves lab. By distinguishing old (20--24 months)
from geriatric (over 28 months) mice, Sousa-Victor et al.
have dissected the transcriptional changes associated to the
aging process, that ultimately depends on Polycomb-mediated
silencing of the p16/INK4 locus (Sousa-Victor et al., 2014).
These data provide a partial explanation of why pre-senescent
satellite cells are responsive to a young environment whereas
full gero-conversion is an irreversible, cell autonomous, process.
Future studies aimed to investigate in detail the signals and
molecular mechanisms driving to this point of no return
will be fundamental for the development of novel therapeutic
approaches to delay muscle miss-function with age.
Remarkably, in a recent article from this special issue of
Frontiers in Aging Neurosciences, Formicola et al. demonstrate
that, contrary to what happens in limb muscles, the extra-ocular
muscles (EOM) stem cell niche is resistant to age and disease
(Formicola et al., 2014), probably thanks to the contribution
of a population of muscle-resident cells called PICs (PW1
interstitial cells) (Mitchell et al., 2010; Pannérec et al., 2013).
If this resistance to aging is due to a direct contribution
of PICs to muscle regeneration or to indirect modulation of
satellite cells function still needs to be investigated. It will
also be interesting to understand what makes EOM PICs and
maybe other EOM muscle-resident cell populations such FAPs
(Fibroadipogenic precursors) more resistant to age-dependent
cell-intrinsic changes. FAPs are multi-potent mesenchymal cells
located in the interstitium of muscle fibers (Joe et al., 2010;
Uezumi et al., 2010). During muscle regeneration they support
the myogenic potential of muscle stem cells (Uezumi et al.,
2010; Mozzetta et al., 2013) through the release of paracrine
factors such as Follistatin, the functional antagonist of Myostatin
(Mozzetta et al., 2013). In DMD at late stages of the disease,
the continuous waves of degeneration and regeneration leads
to the conversion of FAPS into fibro-adipocytes, responsible of
the fat and fibrotic deposition that characterize DMD muscles
(Joe et al., 2010; Uezumi et al., 2010; Mozzetta et al., 2013). It
has been recently shown that treatment with HDACi increases
the regeneration potential and prevents the fibro-adipogenic
degeneration of young, but not old, dystrophic muscles (Minetti
et al., 2006; Consalvi et al., 2013; Mozzetta et al., 2013).
HDACis in young mice act in part by regulating the fate of
FAPS towards the myogenic lineage, through a mechanism
involving a microRNA-dependent control of SWI/SNF subunit
composition (Saccone et al., 2014). On the contrary, FAPs
from old dystrophic muscles are resistant to HDACi-induced
chromatin remodeling at muscle loci and fail to activate the
pro-myogenic phenotype (Saccone et al., 2014). Therefore,
age-dependent cell-intrinsic changes in other muscle-resident
populations can also alter the regeneration potential of the
satellite cell pool.
Conclusions and Perspectives
Muscle regeneration is a multi-step process that entails the
coordinated activation and repression of discrete transcriptional
programs. In this review we aimed to highlight the key role of
signaling pathways in transmitting the extra-cellular information
to the chromatin of satellite cells to regulate gene expression. The
temporal pattern of activation in response to extra-cellular cues,
the interplay amongst the pathways and the activation and/or
repression of downstream effectors are fundamental for the fine-
tuned control of muscle regeneration. Deciphering the muscle-
specific chromatin signaling is particularly important for the
rational design of novel pharmacological approaches aimed to
improve satellite cells function in old and diseasedmuscles. Being
pharmacologically manipulable and potentially reversible, both
signaling cascades and the epigenome are attractive targets for
the design of novel therapeutic interventions.
Finally, numerous studies have revealed a striking similarity
between adult and embryonic myogenesis, regarding the
pathways and the mechanisms affecting muscle stem cell
function (see Buckingham and Rigby, 2014). Here we have
focused on how adult muscle stem (satellite) cells activate the
differentiation program in response to regeneration stimuli.
Despite less studied, we speculate similar mechanisms are also
active during embryonic myogenesis and participate to the
successful completion of the myogenic program in response to
developmental cues.
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